Navigation Links
Helicobacter pylori inhibits intercellular communication of cultured gastric cells
Date:10/26/2007

ly, H pylori, especially CagA+ strains, play an important role in the developmental process of gastric cancer.

The results of this article provide an innovative direction to develop new drugs for curing gastric cancer. That means drugs able to restore GJIC in cells with deficient gap junction may be used in the prevention and/or treatment of human gastric cancer.


'/>"/>

Contact: You-De Chang
y.d.chang@wjgnet.com
0086-108-538-1892
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Dietary cure for fighting Helicobacter pylori
2. Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas
3. Helicobacter pylori effectively killed by Sodium nitrite
4. Evidence supporting H.pylori eradication
5. H.Pylori testing recommended in patients with peptic ulcer
6. Receptor for H.pylori Identified in Stomach
7. Omega 3 Fatty acids (fishy oil) Inhibits Breast Cancer Growth
8. Zyflamend inhibits 78 percent of prostate cancer cells
9. Garlic inhibits fungal growth and protects food
10. Antibiotic Inhibits Cancer Gene Activity
11. Study IDs Protein That Inhibits HIV From Growing In Cell Cultures
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Narconon Gulf Coast Announces 300th Graduate From Drug Rehabilitation Program 49455 1Narconon Gulf Coast Announces 300th Graduate From Drug Rehabilitation Program 49455 2Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 1Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 2Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 3Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 4China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31 2009 49452 1China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31 2009 49452 2China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31 2009 49452 3